Cogan syndrome
Cogan Syndrome

Introduction
Cogan Syndrome, also known as Cogan's Syndrome, is a rare autoimmune disorder primarily affecting young adults. It is characterized by recurrent inflammation of the cornea (the front part of the eye) and audio-vestibular symptoms such as vertigo, tinnitus, and hearing loss. First described by Dr. David G. Cogan in 1945, it poses significant risks of deafness or blindness if left untreated.
Symptoms and Presentation
Ocular Symptoms
- Inflammation of the cornea (keratitis)
- Redness and pain in the eyes
- Photophobia (sensitivity to light)
Audio-Vestibular Symptoms
- Episodes of vertigo (dizziness)
- Tinnitus (ringing in the ears)
- Hearing loss, which can progress to deafness
Additional symptoms may include fever, fatigue, and weight loss.
Pathogenesis
The exact cause of Cogan Syndrome is unknown, but it is believed to be an autoimmune disorder. The immune system mistakenly attacks the body's own tissues, particularly affecting the eyes and ears.
Diagnosis
Diagnosis of Cogan Syndrome involves:
- Clinical assessment of symptoms
- Audiometric tests to assess hearing
- Imaging studies, such as MRI, to rule out other conditions
- Blood tests to identify markers of inflammation
Treatment and Management
Treatment focuses on managing symptoms and preventing complications. It may include:
- Corticosteroids to reduce inflammation
- Immunosuppressive drugs for severe cases
- Symptomatic treatment for vertigo and tinnitus
- Regular monitoring of vision and hearing
Prognosis
The prognosis varies. Early diagnosis and treatment can improve outcomes, but some patients may experience progressive hearing loss or vision impairment.
History and Discovery
The classic form of Cogan Syndrome was first described by Dr. David G. Cogan in 1945. His observations laid the groundwork for understanding this rare condition.
References
<references>
</references>
External Links
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


